Dianthus Therapeutics
Biotech company developer of therapeutics and drugs. Learn more
Launch date
Employees
Market cap
€773m
Enterprise valuation
€445m (Public information from Sep 2024)
Share price
$28.1 DNTH
Massachusetts United States (HQ)
Authorizing premium user...